Exploring Three High Growth Tech Stocks In The United States

In the last week, the market has stayed flat, but over the past 12 months, it has risen by 28%, with earnings forecast to grow by 15% annually. In light of these conditions, identifying high growth tech stocks requires a focus on companies with strong innovation potential and robust financial health to capitalize on future opportunities.

Top 10 High Growth Tech Companies In The United States

Name	Revenue Growth	Earnings Growth	Growth Rating
Super Micro Computer	23.83%	24.32%	★★★★★★
Ardelyx	25.47%	69.63%	★★★★★★
Sarepta Therapeutics	23.98%	42.48%	★★★★★★
Alnylam Pharmaceuticals	22.35%	70.61%	★★★★★★
Clene	77.61%	59.19%	★★★★★★
TG Therapeutics	34.86%	56.98%	★★★★★★
Alkami Technology	21.94%	98.60%	★★★★★★
Travere Therapeutics	31.70%	72.51%	★★★★★★
Seagen	22.57%	71.80%	★★★★★★
ImmunoGen	26.00%	45.85%	★★★★★★

Click here to see the full list of 240 stocks from our US High Growth Tech and AI Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

Five9 (NasdaqGM:FIVN)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Five9, Inc. offers intelligent cloud software solutions for contact centers globally, with a market capitalization of approximately $3.24 billion.

Operations: The company generates revenue primarily through its Internet Software & Services segment, totaling $1.00 billion. The business focuses on providing cloud-based solutions for contact centers across various regions, including the United States and India.

Amidst a dynamic tech landscape, Five9's recent strategic moves underscore its commitment to innovation and market adaptation. The company's R&D expenses, crucial for maintaining competitive edge, have notably increased by 10.2% this year. This investment fuels advancements like the Microsoft Teams UC Integration, enhancing agent-expert communication—a key differentiator in the cloud-based contact center software sector. Moreover, with a 68.5% projected growth in earnings and an expected revenue uptick of 10.2%, Five9 is strategically poised to leverage its enhanced offerings and robust partnerships for sustained growth despite recent legal challenges and market volatility.

• Take a closer look at Five9's potential here in our health report.

• Understand Five9's track record by examining our Past report.

Veracyte (NasdaqGM:VCYT)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Veracyte, Inc. is a diagnostics company that operates in the United States and internationally, with a market cap of $3.37 billion.

Operations: The company generates revenue primarily from its diagnostic products, totaling $425.33 million.

Veracyte demonstrates a promising trajectory with a significant turnaround in its financial health, evidenced by a robust net income swing to $15.16 million this quarter from a net loss of $29.62 million year-over-year. This performance is underpinned by an aggressive R&D strategy, where expenses are judiciously deployed towards innovations like the Decipher Prostate Genomic Classifier—critical for enhancing treatment precision in prostate cancer among diverse populations. Notably, the company's revenue growth forecast at 9.5% annually outpaces the broader US market's 9%, reflecting strategic efficacy despite past challenges of shareholder dilution and current unprofitability. With earnings expected to surge by 45.6% annually, Veracyte is poised to capitalize on its specialized offerings in a market increasingly reliant on genomic diagnostics.

• Click here to discover the nuances of Veracyte with our detailed analytical health report.

• Explore historical data to track Veracyte's performance over time in our Past section.

Sea (NYSE:SE)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Sea Limited operates in digital entertainment, e-commerce, and digital financial services across Southeast Asia, Latin America, other parts of Asia, and globally with a market cap of $67.01 billion.

Operations: Sea Limited generates revenue through its digital entertainment, e-commerce, and digital financial services segments. The company operates across Southeast Asia, Latin America, and other global markets. Each segment contributes to its overall business model by offering diverse services in gaming, online retail platforms, and financial technology solutions.

Sea Limited has demonstrated a remarkable turnaround, transitioning from a net loss of $143.98 million to a net income of $153.32 million in the third quarter of 2024, reflecting robust revenue growth from $3.31 billion to $4.33 billion year-over-year. This performance is underpinned by significant R&D investment and strategic shifts in its business operations, aligning with industry trends towards digital and e-commerce solutions which are increasingly critical in today's market. The company's revenue is expected to grow at an annual rate of 15.2%, outperforming the US market projection of 9.1%, with earnings anticipated to surge by 45.3% annually, showcasing Sea's potential to leverage its technological advancements for sustained growth despite current profit margins standing at a modest 0.6%.

• Click to explore a detailed breakdown of our findings in Sea's health report.

• Evaluate Sea's historical performance by accessing our past performance report.

Key Takeaways

• Click here to access our complete index of 240 US High Growth Tech and AI Stocks.
• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com